CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Revenues
Collaboration revenue	$ 42,620	$ 0
Total revenues	42,620	0
Operating expenses
Research and development	6,353,287	8,085,522
In-process research and development	7,000,000	0
General and administrative	7,974,050	6,077,097
Total operating expenses	21,327,337	14,162,619
Loss from operations	(21,284,717)	(14,162,619)
Other income (expense)
Change in fair value of derivative liabilities	0	(3,187,380)
Loss on debt conversion	0	(341,136)
Interest income	1,065	1,214
Interest expense	(720,963)	(1,767,836)
Other income (expense)	182,662	(784,873)
Total other income (expense)	(537,236)	(6,080,011)
Net loss	(21,821,953)	(20,242,630)
Deemed dividend related to Warrant Exchange	(12,546,340)	0
Net loss to common stockholders	$ (34,368,293)	$ (20,242,630)
Shares used in calculating net loss per common share - basic and diluted (in shares)	112,236,110	13,893,819
Net loss per share of common stock - basic and diluted (in USD per share)	$ (0.31)	$ (1.46)
Net loss	$ (21,821,953)	$ (20,242,630)
Other comprehensive income (loss)
Foreign currency translation adjustment	0	(451)
Comprehensive loss	$ (21,821,953)	$ (20,243,081)